Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#121 / 146 Total
AVTE - Aerovate Therapeutics Inc - Stock Price Chart
TickerAVTE [NASD, RUT]
CompanyAerovate Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap489.77MEPS (ttm)-3.03
P/E-EPS this Y-12.28%
Forward P/E-EPS next Y4.10%
PEG-EPS past 5Y-114.14%
P/S-EPS next 5Y-
P/B5.22EPS Q/Q-25.12%
Dividend-Sales Q/Q-
Insider Own36.59%Inst Own64.77%
Insider Trans-2.38%Inst Trans4.19%
Short Float12.00%EarningsMay 13/a
Analyst Recom1.00Target Price44.67
Avg Volume175.07K52W Range9.41 - 32.42
Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gillies HunterCHIEF MEDICAL OFFICERMay 17 '24Option Exercise2.144,0008,5609,602May 17 07:10 PM
Gillies HunterCHIEF MEDICAL OFFICERMay 17 '24Sale21.084,00084,3325,602May 17 07:10 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMay 16 '24Option Exercise2.1410,00021,40010,000May 17 07:10 PM
NOYES TIMOTHY PCHIEF EXECUTIVE OFFICERMay 16 '24Sale21.5810,000215,7550May 17 07:10 PM
Verwijs MarinusCHIEF TECHNICAL OFFICERMay 02 '24Sale21.021,98141,6310May 03 06:00 PM
ZDGE - Zedge Inc - Stock Price Chart
TickerZDGE [AMEX]
CompanyZedge Inc
CountryUSA
IndustryInternet Content & Information
Market Cap40.48MEPS (ttm)-1.20
P/E-EPS this Y147.73%
Forward P/E5.79EPS next Y128.57%
PEG-EPS past 5Y-22.12%
P/S1.43EPS next 5Y-
P/B1.31EPS Q/Q-682.68%
Dividend-Sales Q/Q11.28%
Insider Own18.26%Inst Own15.03%
Insider Trans0.00%Inst Trans-12.93%
Short Float0.09%EarningsMar 15/b
Analyst Recom1.00Target Price7.00
Avg Volume54.37K52W Range1.68 - 5.18
Today 06:30AM Zedge to Join the Russell Microcap Index (ACCESSWIRE)
May-02-24 06:35AM 3 Penny Stocks to Buy Now to Turn $1K Into $133K by 2026 (InvestorPlace)
Mar-27-24 07:00AM Zedge to Present at The LD Micro Invitational XIV (Newsfile)
Mar-25-24 06:30AM Zedge to Present at The LD Micro Invitational XIV (ACCESSWIRE) -7.72%
Mar-16-24 09:50AM Zedge, Inc. (AMEX:ZDGE) Q2 2024 Earnings Call Transcript (Insider Monkey)
12:24AM Q2 2024 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-24 06:30AM Zedge Announces Second Quarter Fiscal 2024 Results (ACCESSWIRE) -18.80%
Mar-08-24 06:30AM Zedge To Report Second Fiscal Quarter 2024 Results (ACCESSWIRE)
Dec-19-23 08:19AM Zedge, Inc. (AMEX:ZDGE) Q1 2024 Earnings Call Transcript (Insider Monkey)
Dec-14-23 06:27AM Q1 2024 Zedge Inc Earnings Call (Thomson Reuters StreetEvents)
Zedge, Inc. engages in the provision of digital marketplace, games, and content platforms. It operates through the Zedge Marketplace and GuruShots segments. The company was founded by Tom Arnoy in 2008 and is headquartered in New York, NY.
GRRR - Gorilla Technology Group Inc - Stock Price Chart
TickerGRRR [NASD]
CompanyGorilla Technology Group Inc
CountryUnited Kingdom
IndustrySoftware - Infrastructure
Market Cap53.82MEPS (ttm)-
P/E-EPS this Y-115.60%
Forward P/E-EPS next Y48.72%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B7.80EPS Q/Q305.79%
Dividend-Sales Q/Q97.64%
Insider Own25.44%Inst Own1.98%
Insider Trans0.00%Inst Trans-62.56%
Short Float4.95%EarningsApr 08/b
Analyst Recom1.00Target Price43.00
Avg Volume343.06K52W Range4.79 - 69.80
Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.
CISS - C3is Inc - Stock Price Chart
TickerCISS [NASD]
CompanyC3is Inc
CountryGreece
IndustryMarine Shipping
Market Cap2.76MEPS (ttm)162.76
P/E0.01EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.07EPS next 5Y-
P/B0.04EPS Q/Q-76.34%
Dividend-Sales Q/Q305.86%
Insider Own23.08%Inst Own8.61%
Insider Trans0.00%Inst Trans-
Short Float49.68%EarningsMay 28/b
Analyst Recom-Target Price-
Avg Volume1.59M52W Range1.11 - 2000.00
C3is, Inc. is a holding company that engages in the provision of seaborne transportation services to dry bulk charterers through its subsidiaries. It offers services to dry bulk charterers such as national and private industrial users, commodity producers, and commodity traders. The company was founded on July 25, 2022 and is headquartered in Athens, Greece.
TPST - Tempest Therapeutics Inc - Stock Price Chart
TickerTPST [NASD]
CompanyTempest Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap75.10MEPS (ttm)-1.72
P/E-EPS this Y25.81%
Forward P/E-EPS next Y-8.71%
PEG-EPS past 5Y62.66%
P/S-EPS next 5Y-
P/B3.64EPS Q/Q35.92%
Dividend-Sales Q/Q-
Insider Own21.34%Inst Own6.45%
Insider Trans0.00%Inst Trans-0.21%
Short Float9.59%EarningsMay 09/a
Analyst Recom1.00Target Price19.50
Avg Volume871.94K52W Range0.17 - 9.77
Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
FTHM - Fathom Holdings Inc - Stock Price Chart
TickerFTHM [NASD]
CompanyFathom Holdings Inc
CountryUSA
IndustryReal Estate Services
Market Cap37.32MEPS (ttm)-1.42
P/E-EPS this Y60.52%
Forward P/E-EPS next Y85.00%
PEG-EPS past 5Y-64.63%
P/S0.11EPS next 5Y-
P/B0.72EPS Q/Q13.23%
Dividend-Sales Q/Q-9.08%
Insider Own37.82%Inst Own21.52%
Insider Trans-5.71%Inst Trans-11.57%
Short Float1.72%EarningsMay 09/a
Analyst Recom1.00Target Price4.50
Avg Volume74.53K52W Range1.32 - 8.20
Fathom Holdings, Inc. is a national, technology driven, end to end real estate services company, which engages in the provision of residential, brokerage, mortgage, title, insurance, and SaaS offerings for brokers and agents. It operates through the following segments: Real Estate Brokerage, Mortgage, Technology, and Corporate and Other Services. The company was founded by Joshua Harley in January 2010 and is headquartered in Cary, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Flanders Scott NDirectorMay 29 '24Buy1.757001,225602,215May 29 04:53 PM
Flanders Scott NDirectorMay 24 '24Buy1.703,0665,203601,515May 29 04:53 PM
Flanders Scott NDirectorMay 23 '24Buy1.532,1143,234598,449May 23 05:39 PM
Flanders Scott NDirectorMay 22 '24Buy1.6525,00041,250596,335May 23 05:39 PM
Flanders Scott NDirectorMay 21 '24Buy1.651,2512,059571,335May 23 05:39 PM
SCLX - Scilex Holding Company - Stock Price Chart
TickerSCLX [NASD]
CompanyScilex Holding Company
CountryUSA
IndustryDrug Manufacturers - General
Market Cap206.56MEPS (ttm)-0.89
P/E-EPS this Y41.02%
Forward P/E-EPS next Y38.41%
PEG-EPS past 5Y-
P/S4.39EPS next 5Y-
P/B-EPS Q/Q-9.63%
Dividend-Sales Q/Q2.85%
Insider Own37.89%Inst Own15.96%
Insider Trans0.38%Inst Trans-8.47%
Short Float7.18%Earnings-
Analyst Recom1.00Target Price5.75
Avg Volume1.07M52W Range0.73 - 8.30
May-24-24 01:40PM Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index (GlobeNewswire)
09:00AM Scilex Holding Company Sends Letter to U.S. House of Representatives on Illegal Market Manipulation of the Common Stock of Scilex Holding Company (GlobeNewswire)
May-14-24 09:00AM Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex's intent to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba (GlobeNewswire)
08:53AM SCLX Stock Earnings: Scilex Holding Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-13-24 09:00AM Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock (GlobeNewswire) +7.98%
Apr-25-24 04:01PM Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering (GlobeNewswire)
Apr-24-24 08:00AM Scilex Holding Company Announces $15 Million Registered Direct Offering (GlobeNewswire) -12.97%
Apr-16-24 09:00AM Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses (GlobeNewswire) -9.38%
Apr-09-24 09:00AM Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido and ELYXYB for Commercially Insured Patients and the addition of ELYXYB to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool (GlobeNewswire)
Mar-27-24 09:00AM Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend (GlobeNewswire) +6.62%
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHAH JAISIMSee RemarksMay 17 '24Buy0.9256,93952,099155,882May 17 05:36 PM
Chun JayDirectorMay 17 '24Buy0.9057,50051,641102,500May 17 06:41 PM
Ji HenryExecutive ChairpersonMay 17 '24Buy0.8850,00043,98550,070May 17 06:42 PM
Ma Stephen HoiChief Financial OfficerMay 17 '24Buy0.8814,14012,44314,140May 17 04:29 PM
SHAH JAISIMSee RemarksMay 16 '24Buy0.8483,06169,84698,943May 17 05:36 PM
SGHT - Sight Sciences Inc - Stock Price Chart
TickerSGHT [NASD, RUT]
CompanySight Sciences Inc
CountryUSA
IndustryMedical Devices
Market Cap314.48MEPS (ttm)-1.12
P/E-EPS this Y9.12%
Forward P/E-EPS next Y20.28%
PEG-EPS past 5Y-30.17%
P/S3.86EPS next 5Y-
P/B2.87EPS Q/Q6.78%
Dividend-Sales Q/Q2.34%
Insider Own45.05%Inst Own32.07%
Insider Trans-11.05%Inst Trans-3.38%
Short Float4.54%EarningsMay 02/a
Analyst Recom2.67Target Price6.10
Avg Volume156.40K52W Range1.04 - 9.73
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bauerlein AlisonChief Financial OfficerMay 17 '24Sale5.4213,06670,870413,182May 20 08:56 PM
Badawi PaulPresident and CEOApr 03 '24Sale5.0812,57163,8485,750,729Apr 04 07:25 PM
Bauerlein AlisonChief Financial OfficerApr 03 '24Sale5.0810,12351,415426,248Apr 04 07:19 PM
HAYDEN JEREMY B.Chief Legal OfficerApr 03 '24Sale5.084,89324,852168,620Apr 04 07:26 PM
Park Sam BoongChief Operating OfficerApr 03 '24Sale5.083,41417,340261,754Apr 04 07:24 PM
AONC - American Oncology Network Inc - Stock Price Chart
TickerAONC [NASD]
CompanyAmerican Oncology Network Inc
CountryUSA
IndustryMedical Care Facilities
Market Cap23.88MEPS (ttm)-2.76
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.02EPS next 5Y-
P/B-EPS Q/Q-10916.81%
Dividend-Sales Q/Q-
Insider Own64.68%Inst Own2.21%
Insider Trans0.00%Inst Trans10.01%
Short Float0.32%EarningsMay 15/b
Analyst Recom-Target Price-
Avg Volume25.52K52W Range1.50 - 39.60
American Oncology Network, Inc. engages in the provision of community-based oncology management. The company was founded in 2018 and is headquartered in Fort Myers, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Saba Capital Management, L.P.10% OwnerSep 25 '23Sale10.50205,5122,157,8760Sep 25 05:59 PM
FRSX - Foresight Autonomous Holdings Ltd ADR - Stock Price Chart
TickerFRSX [NASD]
CompanyForesight Autonomous Holdings Ltd ADR
CountryIsrael
IndustryAuto Parts
Market Cap17.63MEPS (ttm)-1.35
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y14.49%
P/S32.65EPS next 5Y-
P/B1.26EPS Q/Q76.48%
Dividend-Sales Q/Q83.64%
Insider Own-Inst Own6.58%
Insider Trans-Inst Trans-
Short Float3.29%EarningsMay 28/b
Analyst Recom1.00Target Price4.62
Avg Volume445.16K52W Range0.90 - 3.29
Foresight Autonomous Holdings Ltd. is engaged in the research and development of vehicular accident prevention products. Its product is QuadSight, a multi-spectral vision solution for detection of obstacles in harsh lightining and weather conditions. The company was founded by Haim Siboni on September 19, 1977 and is headquartered in Ness Ziona, Israel.
189101112131415